As of 2026-09-25, the Relative Valuation of Deciphera Pharmaceuticals Inc (DCPH) is (61.21) USD. This relative valuation is based on P/E multiples. With the latest stock price at 25.59 USD, the upside of Deciphera Pharmaceuticals Inc based on Relative Valuation is -339.2%.
The range of the Relative Valuation is (55.49) - (66.28) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 25.1x - 30.1x | 27.6x |
| Forward P/E multiples | 25.2x - 30.8x | 28.0x |
| Fair Price | (55.49) - (66.28) | (61.21) |
| Upside | -316.8% - -359.0% | -339.2% |
| Date | P/E |